Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Improving Design, Evaluation and Analysis of early drug development Studies

Dal 2015-01-01 al 2018-12-31, progetto in corso

Dettagli del progetto

Costo totale:

EUR 3 108 939,48

Contributo UE:

EUR 3 108 939,48

Coordinato in:

United Kingdom

Invito a presentare proposte:

H2020-MSCA-ITN-2014See other projects for this call

Meccanismo di finanziamento:

MSCA-ITN-ETN - European Training Networks

Obiettivo

Coordinatore

LANCASTER UNIVERSITY
United Kingdom

Contributo UE: EUR 819 863,64


BAILRIGG
LA1 4YW LANCASTER
United Kingdom
Activity type: Higher or Secondary Education Establishments

Partecipanti

MEDIZINISCHE UNIVERSITAET WIEN
Austria

Contributo UE: EUR 511 868,16


SPITALGASSE
1090 WIEN
Austria
Activity type: Higher or Secondary Education Establishments
POLITECNICO DI TORINO
Italy

Contributo UE: EUR 516 122,64


CORSO DUCA DEGLI ABRUZZI 24
10129 TORINO
Italy
Activity type: Higher or Secondary Education Establishments
INSTITUT CURIE
Partecipazione terminata
France

Contributo UE: EUR 0


rue d'Ulm 26
75231 PARIS
France
Activity type: Research Organisations
Bayer AG
Germany

Contributo UE: EUR 249 216,48


Muellerstr.
13353 Berlin
Germany
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITAET BREMEN
Germany

Contributo UE: EUR 498 432,96


Bibliothekstrasse 1
28359 BREMEN
Germany
Activity type: Higher or Secondary Education Establishments
JANSSEN PHARMACEUTICA NV
Belgium

Contributo UE: EUR 250 560


TURNHOUTSEWEG 30
2340 BEERSE
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
France

Contributo UE: EUR 262 875,60


101 Rue de Tolbiac
75654 PARIS
France
Activity type: Higher or Secondary Education Establishments
Numero di registrazione: 193243 / Ultimo aggiornamento: 2017-02-14